Tissue-specific dysregulation of cortisol regeneration by 11βHSD1 in obesity: has it promised too much?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tissue-specific dysregulation of cortisol regeneration by 11βHSD1 in obesity: has it promised too much?
Authors
Keywords
11β-Hydroxysteroid dehydrogenase type 1, 11βHSD1 inhibitors, Cortisol, Glucocorticoid metabolism, Obesity, Type 2 diabetes
Journal
DIABETOLOGIA
Volume 57, Issue 6, Pages 1100-1110
Publisher
Springer Nature
Online
2014-04-07
DOI
10.1007/s00125-014-3228-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of 11β-hydroxysteroid dehydrogenase-1 inhibition on hepatic glycogenolysis and gluconeogenesis
- (2013) J. J. Winnick et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitors Still Improve Metabolic Phenotype in Male 11β-HSD1 Knockout Mice Suggesting Off-Target Mechanisms
- (2013) Erika Harno et al. ENDOCRINOLOGY
- 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis
- (2013) Tiina Kipari et al. FASEB JOURNAL
- The Postprandial Rise in Plasma Cortisol in Men Is Mediated by Macronutrient-Specific Stimulation of Adrenal and Extra-Adrenal Cortisol Production
- (2013) Roland H. Stimson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- 11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects
- (2013) Ana Tiganescu et al. JOURNAL OF CLINICAL INVESTIGATION
- 11β-Hydroxysteroid Dehydrogenase Type 1 Gene Knockout Attenuates Atherosclerosis and In Vivo Foam Cell Formation in Hyperlipidemic apoE−/− Mice
- (2013) Ricardo A. García et al. PLoS One
- Local blockade of glucocorticoid activation reverses stress- and glucocorticoid-induced delays in cutaneous wound healing
- (2013) Jong-Kyung Youm et al. WOUND REPAIR AND REGENERATION
- Emodin, an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob mice
- (2012) Yue-jing Wang et al. ACTA PHARMACOLOGICA SINICA
- Salicylate Downregulates 11 -HSD1 Expression in Adipose Tissue in Obese Mice and in Humans, Mediating Insulin Sensitization
- (2012) M. Nixon et al. DIABETES
- Recycling Between Cortisol and Cortisone in Human Splanchnic, Subcutaneous Adipose, and Skeletal Muscle Tissues In Vivo
- (2012) K. A. Hughes et al. DIABETES
- Lack of Significant Metabolic Abnormalities in Mice with Liver-Specific Disruption of 11β-Hydroxysteroid Dehydrogenase Type 1
- (2012) Gareth G. Lavery et al. ENDOCRINOLOGY
- Association of 11β-hydroxysteroid dehydrogenase type I expression and activity with estrogen receptor β in adipose tissue from postmenopausal women
- (2012) Kerry J. McInnes et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- PPARs: Fatty acid sensors controlling metabolism
- (2012) Lars la Cour Poulsen et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Increased Whole-Body and Sustained Liver Cortisol Regeneration by 11β-Hydroxysteroid Dehydrogenase Type 1 in Obese Men With Type 2 Diabetes Provides a Target for Enzyme Inhibition
- (2011) Roland H. Stimson et al. DIABETES
- Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome
- (2011) P. U. Feig et al. DIABETES OBESITY & METABOLISM
- Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
- (2011) Zoi Michailidou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efficacy and safety of the selective 11β-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertension
- (2011) Sukrut Shah et al. Journal of the American Society of Hypertension
- Liver Upregulation of Genes Involved in Cortisol Production and Action Is Associated with Metabolic Syndrome in Morbidly Obese Patients
- (2011) Esther Torrecilla et al. OBESITY SURGERY
- Effect of 11β-hydroxysteroid dehydrogenase-1 inhibition on hepatic glucose metabolism in the conscious dog
- (2010) Dale S. Edgerton et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Improved heart function follows enhanced inflammatory cell recruitment and angiogenesis in 11βHSD1-deficient mice post-MI
- (2010) Sara J. McSweeney et al. CARDIOVASCULAR RESEARCH
- The 11- -Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy
- (2010) J. Rosenstock et al. DIABETES CARE
- A Nonlinear Relationship of Generalized and Central Obesity with Diurnal Cortisol Secretion in the Whitehall II Study
- (2010) Meena Kumari et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Partial Deficiency or Short-Term Inhibition of 11 -Hydroxysteroid Dehydrogenase Type 1 Improves Cognitive Function in Aging Mice
- (2010) K. Sooy et al. JOURNAL OF NEUROSCIENCE
- Metabolic Syndrome in Cushing’s Syndrome
- (2010) Philippe Chanson et al. NEUROENDOCRINOLOGY
- 11 -Hydroxysteroid Dehydrogenase Type 1 Regulates Glucocorticoid-Induced Insulin Resistance in Skeletal Muscle
- (2009) S. A. Morgan et al. DIABETES
- Lack of regulation of 11β-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism
- (2009) Helga A Sigurjonsdottir et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Omental Adipose Tissue Type 1 11β-Hydroxysteroid Dehydrogenase Oxoreductase Activity, Body Fat Distribution, and Metabolic Alterations in Women
- (2009) Alain Veilleux et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Preliminary report: pharmacologic 11β-hydroxysteroid dehydrogenase type 1 inhibition increases hepatic fat oxidation in vivo and expression of related genes in rats fed an obesogenic diet
- (2009) Magalie Berthiaume et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Estrogen Reduces 11β-Hydroxysteroid Dehydrogenase Type 1 in Liver and Visceral, but Not Subcutaneous, Adipose Tissue in Rats
- (2009) Therése Andersson et al. Obesity
- Overexpression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Hepatic and Visceral Adipose Tissue is Associated with Metabolic Disorders in Morbidly Obese Patients
- (2009) René Baudrand et al. OBESITY SURGERY
- Tissue-Specific Increases in 11β-Hydroxysteroid Dehydrogenase Type 1 in Normal Weight Postmenopausal Women
- (2009) Therése Andersson et al. PLoS One
- Cortisol Release From Adipose Tissue by 11 -Hydroxysteroid Dehydrogenase Type 1 in Humans
- (2008) R. H. Stimson et al. DIABETES
- Liver Is the Site of Splanchnic Cortisol Production in Obese Nondiabetic Humans
- (2008) R. Basu et al. DIABETES
- Impaired Glucose Tolerance and Insulin Resistance Are Associated With Increased Adipose 11 -Hydroxysteroid Dehydrogenase Type 1 Expression and Elevated Hepatic 5 -Reductase Activity
- (2008) J. W. Tomlinson et al. DIABETES
- The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study
- (2008) J. Koska et al. DIABETOLOGIA
- Depot-specific Regulation of the Conversion of Cortisone to Cortisol in Human Adipose Tissue
- (2008) Mi-Jeong Lee et al. Obesity
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started